1. Introduction to new areas of use for iotrolan

   • P. Aspelin

   OriginalPaper Pages: S1 - S2

2. From iodide to iotrolan: history and argument

   • M. Sovak

   OriginalPaper Pages: S3 - S7

3. Preclinical findings with iotrolan: a short review

   • U. Speck

   OriginalPaper Pages: S8 - S13

4. Myelography: current status and post-marketing experience with iotrolan

   • K. Ringel

   OriginalPaper Pages: S14 - S17

5. Arthrography of the glenohumeral joint: experience with a non-ionic dimeric contrast agent and future perspectives

   • L. Kopka
   • M. Funke
   • E. Grabbe

   OriginalPaper Pages: S18 - S23

6. A Japanese phase III multicenter comparison of iotrolan 280 with iopamidol 300 in peripheral arteriography

   • S. Hori

   OriginalPaper Pages: S24 - S29

7. Peripheral and penile angiography with iotrolan 280 versus non-ionic monomers: results of the European clinical phase II and III trials

   • J. K. Gmeinwieser
   • B. -I. Wenzel-Hora

   OriginalPaper Pages: S30 - S38

8. Iotrolan in cerebral angiography: a Japanese phase III multicenter comparative study with iopamidol

   • H. Sumie
   • H. Katayama

   OriginalPaper Pages: S39 - S44

9. Iotrolan, a non-ionic dimeric contrast agent in cerebral angiography

   • S. Bien

   OriginalPaper Pages: S45 - S48

10. A Japanese multicenter comparison of iotrolan 280 with iopamidol 300 in head CT

    • K. Sakurai

    OriginalPaper Pages: S49 - S53

11. Iotrolan in head and body CT — European experience

    • O. Schubiger
    • M. Friedrich
    • W. Rodl

    OriginalPaper Pages: S54 - S57

12. A Japanese multicenter comparison of iotrolan 280 with iopamidol 300 in intravenous urography

    • Y. Narimatsu
    • K. Hiramatsu

    OriginalPaper Pages: S58 - S62

13. Iotrolan in urography: efficacy and tolerance in comparison with iohexol and iopamidol

    • J. M. G. Adolph
    • H. Engelkamp
    • B. I. Wenzel-Hora

    OriginalPaper Pages: S63 - S68

14. Iotrolan in pediatric examinations

    • J. Tröger
    • B. I. Wenzel-Hora
    • K. Darge

    OriginalPaper Pages: S69 - S73

15. The effect of contrast agents on renal function

    • S. Dorph

    OriginalPaper Pages: S74 - S78

16. Renal tolerance of iotrolan 280 —a meta-analysis of 14 double-blind studies

    • W. Clauß
    • J. Dinger
    • C. Meißner

    OriginalPaper Pages: S79 - S84

17. Clinical safety assessment of iotrolan 280 in European clinical studies

    • O. M. Silvay-Mandeau
    • C. Meissner
    • B. I. Wenzel-Hora

    OriginalPaper Pages: S85 - S88

18. Clinical safety of iotrolan 280: the Japanese experience

    • C. Brünger

    OriginalPaper Pages: S89 - S92

19. Intravascular iotrolan in the US: work in progress

    • H. A. Goldstein
    • G. Jacob

    OriginalPaper Pages: S93 - S95

20. Future directions in computerized tomography

    • W. E. Torres

    OriginalPaper Pages: S96 - S98

21. Future directions in vascular interventional radiology

    • M. A. Bettmann

    OriginalPaper Pages: S99 - S102

22. The non-ionic dimers — some theoretical and clinical considerations

    • P. Dawson

    OriginalPaper Pages: S103 - S106

23. Looking into the future: iotrolan and beyond

    • H. P. Niendorf
    • T. Fritzsch
    • R. Schürmann

    OriginalPaper Pages: S107 - S111